Companies: 48,874 Total Market Cap: 132455990692658.24

AstraZeneca PLC

NASDAQ: AZN
Healthcare Drug Manufacturers - General
Rank #59
Market Cap 214.95 B
Volume 5.30 M
Price 69.69
Change (%) 1.28%
Country or region United Kingdom United Kingdom

AstraZeneca PLC's latest marketcap:

214.95 B

As of 05/20/2025, AstraZeneca PLC's market capitalization has reached $214.95 B. According to our data, AstraZeneca PLC is the 59th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 214.95 B
Revenue (ttm) 54.98 B
Net Income (ttm) 7.77 B
Shares Out 1.55 B
EPS (ttm) 4.97
Forward PE 15.01
Ex-Dividend Date 02/21/2025
Earnings Date 04/29/2025
Market Cap Chart
Data Updated: 05/20/2025

AstraZeneca PLC's yearly market capitalization.

AstraZeneca PLC has seen its market value grow from $67.00 B to $214.95 B since 2000, representing a total increase of 220.82% and an annual compound growth rate (CAGR) of 4.90%.
Date Market Cap Change (%)
05/20/2025 $214.95 B 3.13%
12/31/2024 $203.11 B -2.65%
12/29/2023 $208.65 B -0.6%
12/30/2022 $209.91 B 20.44%
12/31/2021 $174.28 B 32.86%
12/31/2020 $131.17 B 1.42%
12/31/2019 $129.34 B 34.47%
12/31/2018 $96.18 B 9.54%
12/29/2017 $87.81 B 27.12%
12/30/2016 $69.07 B -19.47%
12/31/2015 $85.77 B -3.07%
12/31/2014 $88.48 B 19.53%
12/31/2013 $74.02 B 21.17%
12/31/2012 $61.09 B -6.34%
12/30/2011 $65.22 B -2.68%
12/31/2010 $67.02 B -1.37%
12/31/2009 $67.95 B 13.67%
12/31/2008 $59.78 B -7.97%
12/31/2007 $64.96 B -23.07%
12/29/2006 $84.44 B 6.23%
12/30/2005 $79.49 B 29.74%
12/31/2004 $61.26 B -26.15%
12/31/2003 $82.95 B 37.87%
12/31/2002 $60.17 B 0.67%
12/28/2001 $59.77 B -10.8%
12/29/2000 $67.00 B

Company Profile

AstraZeneca PLC Overview

AstraZeneca PLC is a leading biopharmaceutical company specializing in the discovery, development, manufacture, and commercialization of prescription medicines.

Key Products

  • Oncology: Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex
  • Cardiovascular & Renal: Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa
  • Respiratory & Immunology: Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra
  • Vaccines & Immune Therapies: Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Beyfortus, Synagis, FluMist, Evusheld
  • Rare Diseases: Wainua, Atacand, Plendil, Modip, Splendil, Munobal, Flodil

Therapeutic Areas

AstraZeneca's products cater to multiple therapeutic areas, including:

  • Oncology
  • Cardiovascular, Renal & Metabolism
  • Respiratory & Immunology
  • Vaccines & Immune Therapies
  • Rare Diseases

Global Presence

The company serves primary and specialty care physicians through distributors and local representative offices across:

  • United Kingdom
  • United States
  • Europe
  • Asia

Company Background

Originally known as Zeneca Group PLC, the company rebranded as AstraZeneca PLC in April 1999. Founded in 1992, it is headquartered in Cambridge, United Kingdom.

Frequently Asked Questions

As of 05/20/2025, AstraZeneca PLC (including the parent company, if applicable) has an estimated market capitalization of $214.95 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

AstraZeneca PLC global market capitalization ranking is approximately 59 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United Kingdom
Founded 1992
IPO Date 05/12/1993
Employees 94,300
CEO Pascal Claude Soriot
Sector Healthcare
Industry Drug Manufacturers - General
Address 1 Francis Crick Avenue
Cambridge, CB2 0AA
United Kingdom
Website https://www.astrazeneca.com
People Also Watch
Eli Lilly
755.11 1.28%
JNJ
152.49 1.28%
AbbVie
185.71 1.28%
Novo Nordisk
67.02 1.28%